Related Experiment Video
Updated: Aug 8, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
The Interplay between Noncoding RNAs and p21 Signaling in Gastrointestinal Cancer: From Tumorigenesis to Metastasis
Farzad Rahmani1,2,3, Mehrdad Zandigohar4, Pegah Safavi5
1Department of Clinical Biochemistry, Kashmar School of Nursing, Mashhad University of Medical Sciences, Mashhad, Iran.
Non-coding RNAs (ncRNAs) regulate the cell cycle protein p21, impacting gastrointestinal cancer. Understanding these ncRNA-p21 interactions may reveal new therapeutic targets for GI cancers.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Non-coding RNAs (ncRNAs) are key regulators in cancer, influencing cell cycle progression, proliferation, and invasion.
- The cell cycle regulator p21 plays a dual role (tumor-suppressive or oncogenic) in cancer, affecting DNA damage response, growth, and metastasis.
- p21 modulates cell cycle checkpoints (G1/S and G2/M) by interacting with cyclin-dependent kinases (CDKs) and proliferating cell nuclear antigen (PCNA).
Purpose of the Study:
- To review the mechanisms by which microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) regulate p21 signaling.
- To explore the impact of ncRNA-mediated p21 regulation on gastrointestinal (GI) tumorigenesis.
- To highlight the potential of targeting the ncRNA-p21 axis for novel GI cancer therapies.
Main Methods:
- Literature review of studies on ncRNAs, p21, and GI cancer.
- Analysis of transcriptional and post-transcriptional regulation of p21 by ncRNAs.
- Examination of p21's role in cell cycle control and DNA damage response.
Main Results:
- ncRNAs, including miRNAs and lncRNAs, significantly regulate p21 expression and function.
- Dysregulation of the ncRNA-p21 axis is implicated in the initiation and progression of GI cancers.
- p21's complex roles in cell cycle arrest, DNA repair, and apoptosis are modulated by specific ncRNAs.
Conclusions:
- ncRNAs are critical players in modulating p21's function in the context of GI cancer.
- Targeting specific ncRNA-p21 interactions presents a promising avenue for developing novel therapeutic strategies.
- Further research into ncRNA-p21 pathways could uncover new biomarkers and treatments for gastrointestinal malignancies.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Non-Canonical Wnt Signaling Pathways
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...